Embark Overview

  • Founded

  • 2015

Founded
  • Status

  • Private

  • Employees

  • 186

Employees
  • Latest Deal Type

  • Series B

  • Latest Deal Amount

  • $75M

  • Investors

  • 20

Embark General Information

Description

Developer of a DNA testing kit designed to improve dog health and wellness. The company's kit tracks genetic markers to empower dog owners with vital health information, offering ancestry analysis as well as key insights into genetic disease risk and heritable traits, enabling pet owners to learn about their dog's breed, health, and diseases, all with a simple cheek swab.

Contact Information

Website
www.embarkvet.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Consumer Durables
Other Industries
Other Services (B2C Non-Financial)
Primary Office
  • 320 Summer Street
  • Floor 6
  • Boston, MA 02110
  • United States
+1 (224) 000-0000

Embark Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Embark Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 26-Jul-2021 $75M 000.00 00000 Completed Generating Revenue
5. Early Stage VC (Series A) 29-Mar-2019 000.00 000.00 000.00 Completed Generating Revenue
4. Seed Round 26-Jun-2017 00.000 00.000 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
2. Angel (individual) 01-Jan-2016 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Embark’s complete valuation and funding history, request access »

Embark Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series A-2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A-1 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Seed 4 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 3 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 2 486,969 $0.000100 5% $0.53 $0.53 1x $0.53 1.18%
Seed 1 6,801,684 $0.000100 5% $0.66 $0.66 1x $0.66 16.48%
To view Embark’s complete cap table history, request access »

Embark Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a DNA testing kit designed to improve dog health and wellness. The company's kit tracks genetic markers to
Other Consumer Durables
Boston, MA
186 As of 2022
000.00
0000 0000-00-00
00000000000 000.00

000000

orem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore e
0000000000 00000000 (0000000000)
Vancouver, WA

000000

n ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
0000000000 00000000 (0000000000)
Hartford, CT
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Embark Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Wisdom Panel Corporation Vancouver, WA
000000 00000000 Corporation Hartford, CT
0000 Private Debt Financed Hackettstown, NJ 000000 00.00 000000000 00.00
You’re viewing 3 of 3 competitors. Get the full list »

Embark Executive Team (19)

Name Title Board Seat Contact Info
Ryan Boyko Ph.D Co-Founder, Chief Executive Officer & Board Member
Adam Medros Chief Operating Officer
Matt Barton Chief Technology Officer
Isabelle Plante Chief Marketing Officer
Adam Boyko Co-Founder, Chief Science Officer & Board Member
You’re viewing 5 of 19 executive team members. Get the full list »

Embark Board Members (7)

Name Representing Role Since
Adam Boyko Embark Co-Founder, Chief Science Officer & Board Member 000 0000
Carl Byers F-Prime Capital Board Member 000 0000
Carlos Bustamante Ph.D F-Prime Capital Board Observer 000 0000
Eric Paley Founder Collective Board Member 000 0000
Lydia Jett Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Embark Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Embark Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Eight Roads Venture Capital Minority 000 0000 000000 0
SoftBank Investment Advisers Growth/Expansion Minority 000 0000 000000 0
F-Prime Capital Venture Capital Minority 000 0000 000000 0
Material Companies Venture Capital Minority 000 0000 000000 0
3rdKind VC-Backed Company Minority 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »

Ready to get started?

Request a free trial

Embark Subsidiaries (1)

Company Name Industry Location Founded
000000000 00000000 Public Pension Fund Salisbury, United Kingdom 0000
To view Embark’s complete subsidiaries history, request access »